博客

MSC Therapy for Pulmonary Arterial Hypertension: Mechanisms, Mitochondrial Repair.

Pulmonary arterial hypertension kills half its patients within five years. 2026 research shows mesenchymal stem cells — especially HO-1-modified and mitochondria-primed MSCs — are reversing the vascular remodeling at the…

Aug 12, 2026

Can Stem Cell Exosomes Restore Hearing? What the 2026 Breakthrough Means for You

A 2026 Phase 1 trial showed that MSC-derived exosomes injected into the ear were safe and improved hearing in patients with sudden sensorineural hearing loss. Here’s what the breakthrough means and when it could be avail…

Aug 12, 2026

How Much Does Stem Cell Therapy Cost in 2026? A Patient’s Realistic Guide

Stem cell therapy prices range from $2,000 to $100,000 depending on where you go. Here’s what actually drives the cost, what’s included, and how Thailand compares to the US, Australia, and Europe in 2026.

Jun 25, 2026

MSC Therapy for Inflammatory Bowel Disease: Crohn’s and Ulcerative Colitis in 2026

MSC therapy is offering new hope for IBD patients who don’t respond to conventional biologics. Here’s what the 2026 clinical data shows.

Jun 24, 2026

间充质干细胞细胞外囊泡用于皮肤光老化：山奈酚修饰的细胞外囊泡和ADAM10抑制

山奈酚修饰的间充质干细胞胞外囊泡可抑制ADAM10并修复紫外线损伤的胶原蛋白。这代表了抗衰老皮肤修复的未来方向。.

Jun 23, 2026

Exosome Therapy for ALS: First-Ever Strength Improvement Reported in Clinical Trial

A 2025 clinical trial reports the first-ever strength improvement in ALS patients using intranasally delivered MSC exosomes — zero adverse events across 32 treatments.

Jun 22, 2026

Stem Cell Therapy for Tendon and Ligament Injuries: Beyond PRP

PRP has its limits. For serious tendon and ligament injuries, stem cells are showing results PRP cannot match.

Jun 21, 2026

Senolytic MSC Therapy: Why Clearing Aged Cells First May Unlock Stem Cell Potential

A June 2026 study shows that senolytic preconditioning dramatically improves MSC efficacy by removing the SASP factors that suppress tissue repair. Plus: AAT-MSCs reverse diabetes via immune reprogramming, and a phase II…

Jun 20, 2026

MSC Therapy for Lupus Nephritis: 120-Patient Study Shows 57% Renal Response at 12 Months

A 2026 real-world study followed 120 refractory lupus nephritis patients treated with UC-MSCs. Cumulative renal response reached 56.7% at 12 months with low relapse rates and zero severe adverse events. Here’s what clini…

Jun 20, 2026

Stem Cell Therapy for Sports Injuries: What Weekend Warriors Need to Know

A 36-month clinical trial showed zero adverse events and 57% pain reduction when stem cells were injected into torn rotator cuffs. Here’s what weekend warriors and recreational athletes need to know about MSC therapy for…

Jun 19, 2026

How Exercise Supercharges Your Stem Cells: The Science Behind Movement as Medicine

Every workout floods your bloodstream with stem cells — your body’s own repair crew. Learn how exercise mobilizes regenerative cells and why it matters for aging and healing.

Jun 19, 2026

Intravenous UC-MSCs for Ischemic Stroke: What the MERIT Phase 1 Trial Tells Us

The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.

Jun 19, 2026

Page 4 of 15 — 177 posts